AIDS drug could see mandatory licensing
Government hopes to keep costs low for expansion of preventive program
BEIJING - China is considering mandatory licensing to secure cheaper drugs for HIV/AIDS patients, particularly as the nation's health authority is preparing to expand coverage for the preventive antiretroviral therapy (ART).
Very soon, couples with one partner having HIV/AIDS and the other being negative - estimated at 30,000 on the mainland - will be offered free ART, Hao Yang, deputy director of the disease prevention and control bureau at the Ministry of Health, told China Daily in an exclusive interview.
Photo